A study on the correlation of chronic obstructive pulmonary disease with metabolic syndrome and its components

Bhattacharyya, Aishee; Roy, Avas Chandra; Basu, Subrata; Das, Krishanko

doi:10.61186/rabms.9.4.243

Volume 9, Issue 4 (10-2023) Journal of Research in Applied and Basic Medical Sciences 2023, 9(4): 243-253 | Back to browse issues page

‎ 10.61186/rabms.9.4.243

Mendeley

Zotero

RefWorks

Bhattacharyya A, Roy A C, Basu S, Das K. A study on the correlation of chronic obstructive pulmonary disease with metabolic syndrome and its components. Journal of Research in Applied and Basic Medical Sciences 2023; 9 (4) :243-253
URL: http://ijrabms.umsu.ac.ir/article-1-242-en.html

A study on the correlation of chronic obstructive pulmonary disease with metabolic syndrome and its components

Aishee Bhattacharyya

, Avas Chandra Roy

, Subrata Basu

, Krishanko Das ^*

Post-Doctoral Resident, Department of Cardiology, R.G. Kar Medical College and Hospital, Kolkata, West Bengal, India , kri07@rediffmail.com

Abstract: (1182 Views)

Background & Aims: Background & Aims: COPD and metabolic syndrome are highly prevalent and contribute significantly to morbidity and mortality worldwide. Limited evidence suggests a higher prevalence of metabolic syndrome in COPD patients, indicating a potential link between metabolic syndrome and impaired lung function. We aimed to study the correlation between COPD severity and metabolic syndrome components, and between CRP and COPD severity.
Materials & Methods: This cross-sectional observational study involved 100 COPD outpatients. Metabolic syndrome parameters were assessed using NCEP criteria. Patients were categorized per GOLD classification using MMRC grading and spirometry. We compared blood pressure, blood glucose, cholesterol, triglycerides, and waist circumference across GOLD stages, and clinical, metabolic, and spirometry parameters between those with and without metabolic syndrome. Analysis was performed using GraphPad Prism 9 and SPSS 26.0.
Results: 48% of COPD patients had metabolic syndrome. SBP, blood glucose and triglycerides were significantly higher in severe COPD compared to stages I and II. Among metabolic parameters, blood glucose and SBP were significant negative predictors of FEV1/FVC adjusted for age, smoking and BMI. CRP level, diabetes, hypertension, and abdominal adiposity were associated with airflow limitation severity. FEV1/FVC was significantly lower in extreme BMI groups. Those with metabolic syndrome had higher MMRC grade, exacerbation rate, and CRP, but lower FEV1/FVC and smoking history than those without.
Conclusion: This study emphasizes assessing and managing metabolic syndrome in COPD patients, and suggests links between inflammation, metabolic syndrome, and impaired lung function.

Keywords: Chronic Obstructive Pulmonary Disease, Systolic Blood Pressure, Fasting Blood Glucose, Waist Circumference, Metabolic Syndrome, Forced Expiratory Volume

Full-Text [PDF 323 kb] (351 Downloads) | | Full-Text (HTML) (430 Views)

Type of Study: orginal article | Subject: Special

References

1. Retamales I, Elliott WM, Meshi B, Coxson HO, Pare PD, Sciurba FC, et al. Amplification of Inflammation in Emphysema and Its Association with Latent Adenoviral Infection. Am J Respir Crit Care Med 2001;164(3):469-73. Available from: [DOI:10.1164/ajrccm.164.3.2007149] [PMID]

2. Silverman EK, Speizer FE. RISK Factors for the development of chronic obstructive pulmonary disease. Med Clin North Am 1996;80(3):501-22. [DOI:10.1016/S0025-7125(05)70451-X] [PMID]

3. Harrison DJ, Cantlay AM, Rae F, Lamb D, Smith C. Frequency of glutathione S-transferase M1 deletion in smokers with emphysema and lung cancer. Hum Exp Toxicol 1997;16(7):356-60. Available from: [DOI:10.1177/096032719701600703] [PMID]

4. Otterbein LE, Lee PJ, Chin BY, Petrache I, Camhi SL, Alam J, et al. Protective Effects of Heme Oxygenase-1 in Acute Lung Injury. Chest 1999;116:61S-3S. [DOI:10.1378/chest.116.suppl_1.61S-a] [PMID]

5. Díez-Manglano J, Barquero-Romero J, Almagro P, Cabrera FJ, López García F, Montero L, et al. COPD patients with and without metabolic syndrome: clinical and functional differences. Intern Emerg Med 2014;9(4):419-25. Available from: [DOI:10.1007/s11739-013-0945-7] [PMID]

6. Hurst JR, Donaldson GC, Perera WR, Wilkinson TMA, Bilello JA, Hagan GW, et al. Use of Plasma Biomarkers at Exacerbation of Chronic Obstructive Pulmonary Disease. Am J Respir Crit Care Med 20065;174(8):867-74. Available from: [DOI:10.1164/rccm.200604-506OC] [PMID]

7. Pepys MB, Hirschfield GM. C-reactive protein: a critical update. J Clin Invest 2003;111(12):1805-12. Available from: [DOI:10.1172/JCI18921] [PMID] []

8. Wolf AM, Wolf D, Rumpold H, Enrich B, Tilg H. Adiponectin induces the anti-inflammatory cytokines IL-10 and IL-1RA in human leukocytes. Biochem Biophys Res Commun 2004;323(2):630-5. [DOI:10.1016/j.bbrc.2004.08.145] [PMID]

9. Broekhuizen R, Vernooy JHJ, Schols AMWJ, Dentener MA, Wouters EFM. Leptin as local inflammatory marker in COPD. Respir Med 2005;99(1):70-4. [DOI:10.1016/j.rmed.2004.03.029] [PMID]

10. Cao C, Wang R, Wang J, Bunjhoo H, Xu Y, Xiong W. Body mass index and mortality in chronic obstructive pulmonary disease: A meta-analysis. PLoS One 2012;7(8). [DOI:10.1371/journal.pone.0043892] [PMID] []

11. Imaizumi Y, Eguchi K, Kario K. Lung Disease and Hypertension. Pulse 2014;2(1-4):103-12. [DOI:10.1159/000381684] [PMID] []

12. Clini E, Crisafulli E, Radaeli A, Malerba M. COPD and the metabolic syndrome: an intriguing association. Intern Emerg Med 2013;8(4):283-9. Available from: [DOI:10.1007/s11739-011-0700-x] [PMID]

13. Rogliani P, Lucà G, Lauro D. Chronic obstructive pulmonary disease and diabetes. COPD Research and Practice 2015;1(1):3. Available from: [DOI:10.1186/s40749-015-0005-y]

14. Davis WA, Knuiman M, Kendall P, Grange V, Davis TME. Glycemic Exposure Is Associated With Reduced Pulmonary Function in Type 2 Diabetes: The Fremantle Diabetes Study. Diabetes Care 2004;27(3):752-7 Available from: [DOI:10.2337/diacare.27.3.752] [PMID]

15. Ehrlich SF, Quesenberry CP, Van Den Eeden SK, Shan J, Ferrara A. Patients diagnosed with diabetes are at increased risk for asthma, chronic obstructive pulmonary disease, pulmonary fibrosis, and pneumonia but not lung cancer. Diabetes Care 2010;33(1):55-60. [DOI:10.2337/dc09-0880] [PMID] []

16. Cazzola M, Calzetta L, Rogliani P, Lauro D, Novelli L, Page CP, et al. High glucose enhances responsiveness of human airways smooth muscle via the Rho/ROCK pathway. Am J Respir Cell Mol Biol 2012;47(4):509-16. https://doi.org/10.1165/rcmb.2011-0449OC [DOI:10.1165/rcmb.2011-0449oc] [PMID]

17. Tiengo A, Fadini GP, Avogaro A. The metabolic syndrome, diabetes and lung dysfunction. Diabetes Metab 2008;34(5):447-54. Available from: https://www.sciencedirect.com/science/article/pii/S126236360800164X [DOI:10.1016/j.diabet.2008.08.001] [PMID]

18. Watz H, Waschki B, Kirsten A, Müller KC, Kretschmar G, Meyer T, et al. The metabolic syndrome in patients with chronic bronchitis and COPD: Frequency and associated consequences for systemic inflammation and physical inactivity. Chest 2009;136(4):1039-46. [DOI:10.1378/chest.09-0393] [PMID]

19. Vestbo J, Hurd SS, Agustí AG, Jones PW, Vogelmeier C, Anzueto A, et al. Global strategy for the diagnosis, management, and prevention of chronic obstructive pulmonary disease: GOLD executive summary. Am J Respir Crit Care Med 2013;187(4):347-65. https://doi.org/10.1164/rccm.201204-0596PP [DOI:10.1164/rccm.201204-0596pp] [PMID]

20. Agustí A, Celli BR, Criner GJ, Halpin D, Anzueto A, Barnes P, et al. Global Initiative for Chronic Obstructive Lung Disease 2023 Report: GOLD Executive Summary. Eur Respir J 2023;2300239. [DOI:10.1183/13993003.00239-2023] [PMID] []

21. Bermudez GR, Jasul G, David-Wang A, Jimeno C, Magallanes J, Macalalad-Josue AA. Association of metabolic syndrome with the severity of airflow obstruction in patients with chronic obstructive pulmonary disease. J ASEAN Fed Endocr Soc 2018;33(2):181-7. [DOI:10.15605/jafes.033.02.11] [PMID] []

22. Fekete M, Szollosi G, Tarantini S, Lehoczki A, Nemeth AN, Bodola C, et al. Metabolic syndrome in patients with COPD: Causes and pathophysiological consequences. Physiol Int 2022;109(1):90-105. [DOI:10.1556/2060.2022.00164] [PMID]

23. Kumar Ds, Samuel R, DSouza V, Bangera M. Prevalence of metabolic syndrome in chronic obstructive pulmonary disease and its correlation with body mass index, airflow obstruction, dyspnea, and exercise index and C-reactive protein. Indian J Resp Care 2022;11(4):314. [DOI:10.4103/ijrc.ijrc_44_22]

24. Díez-Manglano J, Barquero-Romero J, Almagro P, Cabrera FJ, López García F, Montero L, et al. COPD patients with and without metabolic syndrome: Clinical and functional differences. Intern Emerg Med 2014;9(4):419-25. [DOI:10.1007/s11739-013-0945-7] [PMID]

25. Bahrami M, Forouharnejad K, Mirgaloyebayat H, Darestani NG, Ghadimi M, Masaeli D, et al. Original Article Correlations and diagnostic tools for metabolic syndrome (MetS) and chronic obstructive pulmonary disease (COPD). Int J Physiol Pathophysiol Pharmacol 2022;14(6):311. Available from: www.ijppp.org [PMID]

26. Kim SH, Park JH, Lee JK, Heo EY, Kim DK, Chung HS. Chronic obstructive pulmonary disease is independently associated with hypertension in men: A survey design analysis using nationwide survey data. Medicine 2017;96(19). https://doi.org/10.1097/MD.0000000000006826 [DOI:10.1097/md.0000000000006826] [PMID] []

27. Foumani AA, Neyaragh MM, Ranjbar ZA, Leyli EK, Ildari S, Jafari A. Waist circumference and spirometric measurements in chronic obstructive pulmonary disease. Osong Public Health Res Perspect 2019;10(4):240-5. [DOI:10.24171/j.phrp.2019.10.4.07] [PMID] []

28. Lam KBH, Jordan RE, Jiang CQ, Thomas GN, Miller MR, Zhang WS, et al. Airflow obstruction and metabolic syndrome: The Guangzhou Biobank Cohort Study. Eur Resp J 2010;35(2):317-23. [DOI:10.1183/09031936.00024709] [PMID]

29. Kumar Jain B, Pasari N, Songra A, Bajpaiv A. The Lipid Profile Parameter in Chronic Obstructive Pulmonary Disease Patients and Correlation with Severity of Disease J Cardiothorac Med. 2017. Available from: www.SID.ir [Google Scholar]

30. Ameen NM, El Deen Mohamed RS, El Mageed NIA, EL Wahab MHA. The metabolic syndrome in patients with chronic obstructive pulmonary disease. Egypt J Chest Dis Tuberc 2016;65(3):593-6. [DOI:10.1016/j.ejcdt.2016.03.008]

31. Rao MV, Raghu S, P SK, Ch HR. A study of lipid profile in chronic obstructive pulmonary disease. J Evol Med Dent Sci 2015;4(42):7287-96. [DOI:10.14260/jemds/2015/1059]

32. Minas M, Kostikas K, Papaioannou AI, Mystridou P, Karetsi E, Georgoulias P, et al. The Association of Metabolic Syndrome with Adipose Tissue Hormones and Insulin Resistance in Patients with COPD without Co-morbidities. J Chron Obstruct Pulmon Dis 2011(6):414-20. Available from: [DOI:10.3109/15412555.2011.619600] [PMID]

33. Wu Z, Yang D, Ge Z, Yan M, Wu N, Liu Y. Body mass index of patients with chronic obstructive pulmonary disease is associated with pulmonary function and exacerbations: A retrospective real-world research. J Thorac Dis 2018; 10:5086-99. [DOI:10.21037/jtd.2018.08.67] [PMID] []

34. Saha A, Barma P, Biswas A, Ghosh S, Malik T, Mitra M, et al. A study of correlation between body mass index and GOLD staging of chronic obstructive pulmonary disease patients. J Assoc Chest Physicians 2013;1(2):58. Available from: http://dx.doi.org/10.4103/2320-8775.123217 [DOI:10.4103/2320-8775.123217]

35. Mahishale V V, Avuthu S, Patil B, Lolly M, Eti A, Khan S. Effect of poor glycemic control in newly diagnosed patients with smear-positive pulmonary tuberculosis and type-2 diabetes mellitus. Iran J Med Sci 2017;42(2):144-51. [DOI:10.4103/2384-5147.151564]

36. McKeever TM, Weston PJ, Hubbard R, Fogarty A. Lung function and glucose metabolism: an analysis of data from the Third National Health and Nutrition Examination Survey. Am J Epidemiol 2005;161(6):546-56. Available from: http://dx.doi.org/10.1093/aje/kwi076. [DOI:10.1093/aje/kwi076] [PMID]

37. Litonjua AA, Lazarus R, Sparrow D, DeMolles D, Weiss ST. Lung function in type 2 diabetes: The Normative Aging Study. Respir Med 2005;99(12):1583-90. [DOI:10.1016/j.rmed.2005.03.023] [PMID]

38. Broekhuizen R, Wouters EFM, Creutzberg EC, Schols AMWJ. Raised CRP levels mark metabolic and functional impairment in advanced COPD. Thorax 2006;61(1):17-22. [DOI:10.1136/thx.2005.041996] [PMID] []

39. Ghatas T. The relationship between metabolic syndrome and chronic obstructive pulmonary disease. Egypt J Bronchol 2017;11(1):11-5. [DOI:10.4103/1687-8426.198983]